NCT07513324 2026-04-07Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)Dana-Farber Cancer InstitutePhase 2 Not yet recruiting116 enrolled